176 related articles for article (PubMed ID: 36401516)
1. Redox Modulation of Mitochondrial Proteins in the Neurotoxicant Models of Parkinson's Disease.
Sarkar A; Rasheed MSU; Singh MP
Antioxid Redox Signal; 2023 Apr; 38(10-12):824-852. PubMed ID: 36401516
[No Abstract] [Full Text] [Related]
2. Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease.
Garcia-Garcia A; Zavala-Flores L; Rodriguez-Rocha H; Franco R
Antioxid Redox Signal; 2012 Dec; 17(12):1764-84. PubMed ID: 22369136
[TBL] [Abstract][Full Text] [Related]
3. Redox imbalance in Parkinson's disease.
Chinta SJ; Andersen JK
Biochim Biophys Acta; 2008 Nov; 1780(11):1362-7. PubMed ID: 18358848
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial Dysfunction Combined with High Calcium Load Leads to Impaired Antioxidant Defense Underlying the Selective Loss of Nigral Dopaminergic Neurons.
Ricke KM; Paß T; Kimoloi S; Fährmann K; Jüngst C; Schauss A; Baris OR; Aradjanski M; Trifunovic A; Eriksson Faelker TM; Bergami M; Wiesner RJ
J Neurosci; 2020 Feb; 40(9):1975-1986. PubMed ID: 32005765
[TBL] [Abstract][Full Text] [Related]
5. Evidence for Oxidative Pathways in the Pathogenesis of PD: Are Antioxidants Candidate Drugs to Ameliorate Disease Progression?
Leathem A; Ortiz-Cerda T; Dennis JM; Witting PK
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805928
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
[TBL] [Abstract][Full Text] [Related]
7. Role of microgliosis, oxidative stress and associated neuroinflammation in the pathogenesis of Parkinson's disease: The therapeutic role of Nrf2 activators.
Jayaram S; Krishnamurthy PT
Neurochem Int; 2021 May; 145():105014. PubMed ID: 33689805
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
9. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
Zuo L; Motherwell MS
Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
[TBL] [Abstract][Full Text] [Related]
10. Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson's disease.
Koppula S; Kumar H; More SV; Lim HW; Hong SM; Choi DK
Molecules; 2012 Sep; 17(10):11391-420. PubMed ID: 23014498
[TBL] [Abstract][Full Text] [Related]
11. Current perspective of mitochondrial biology in Parkinson's disease.
Ammal Kaidery N; Thomas B
Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604
[TBL] [Abstract][Full Text] [Related]
12. Modulation of cellular redox environment as a novel therapeutic strategy for Parkinson's disease.
Deus CM; Teixeira J; Raimundo N; Tucci P; Borges F; Saso L; Oliveira PJ
Eur J Clin Invest; 2022 Oct; 52(10):e13820. PubMed ID: 35638352
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Complex I Reversible S-Nitrosation Improves Bioenergetics and Is Protective in Parkinson's Disease.
Milanese C; Tapias V; Gabriels S; Cerri S; Levandis G; Blandini F; Tresini M; Shiva S; Greenamyre JT; Gladwin MT; Mastroberardino PG
Antioxid Redox Signal; 2018 Jan; 28(1):44-61. PubMed ID: 28816057
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial mechanisms of redox cycling agents implicated in Parkinson's disease.
Lopert P; Patel M
J Neural Transm (Vienna); 2016 Feb; 123(2):113-23. PubMed ID: 25749885
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria as an easy target to oxidative stress events in Parkinson's disease.
Reale M; Pesce M; Priyadarshini M; Kamal MA; Patruno A
CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):430-8. PubMed ID: 22483310
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
17. Genetic modulators associated with regulatory surveillance of mitochondrial quality control, play a key role in regulating stress pathways and longevity in C. elegans.
Sarkar A; Hameed R; Mishra A; Bhatta RS; Nazir A
Life Sci; 2022 Feb; 290():120226. PubMed ID: 34953889
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
Mani S; Sevanan M; Krishnamoorthy A; Sekar S
Neurol Sci; 2021 Nov; 42(11):4459-4469. PubMed ID: 34480241
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in
Martinez BA; Petersen DA; Gaeta AL; Stanley SP; Caldwell GA; Caldwell KA
J Neurosci; 2017 Nov; 37(46):11085-11100. PubMed ID: 29030433
[TBL] [Abstract][Full Text] [Related]
20. Geraniol Protects Against the Protein and Oxidative Stress Induced by Rotenone in an In Vitro Model of Parkinson's Disease.
Rekha KR; Inmozhi Sivakamasundari R
Neurochem Res; 2018 Oct; 43(10):1947-1962. PubMed ID: 30141137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
